Valirx Share Discussion Threads

[sooty snipes] 08/9/2022 10:10

Thanks for your reply Jason. I thought you had been buying over the last couple of years as well as recently. I bought a third of my holding at 10.5p after the fundraise but my other two thirds at 21p and 23p. Hence I'm underwater due to the fundraise which should have been done much earlier to avoid such dilution.

[jasonpugh] 08/9/2022 10:01

Totally agree with you base7.aka suzy Like the way you copied George’s punctuation. . Well said girl. 👏..

[base7] 08/9/2022 09:52

If Francoise is George you should be ashamed of posting on the board of the company that you & Satu almost drove into the ground with regular small fu fraud OGS to keep the lights on & zero respect or trust from the providers of finance .S & K are using the recent fundraise wisely to build a credible team (neither of whom after due diligence woikd associate with a bust flush )which will help us identify more targets & hopefully get Tx ,at very long last ,over the line .Yoh should applau their ability to have rebuilt credibility in a company which cost many PIs a fortune & 1,at least ,a lot more !

[jasonpugh] 08/9/2022 09:27

Simple mathematics. Bought at 11.1 and 10.7 and divided by 2 to get average lol 🧐. This inflow of Rns s are excellent. Come on mr market. I can see you smiling baby ❤️

[sooty snipes] 08/9/2022 09:09

Jason how do you have an average of 10.9p?

[sooty snipes] 08/9/2022 09:08

francoismyname FILTERED

[jasonpugh] 08/9/2022 08:58

Whoever sells at this moment has no clue about how to read an rns. Could it be porky trying to convince himself or herself they are right? 😆lol

[412069] 08/9/2022 08:55

Why would she jump onto a sinking ship?
I know who I would sooner believe.

[francoismyname] 08/9/2022 08:41

50% more shares after placing and options .

10p placing.

No income except the usual dilutions.

More expense with 2 new arrivals.

Paying for services with shares.

Yep all looks Rosy in the garden - NOT

[keremjj] 08/9/2022 08:40

Sounds like, kids playing in play ground

[412069] 08/9/2022 08:33

Mcap should be twice this with no other news which we knows a cert to be positive with today’s announcement.

[jasonpugh] 08/9/2022 08:19

Just wait until big 100k buys hit today. 💥

[nico115] 08/9/2022 08:16

Mkt cap of 11m just ridiculous when we have some blockbuster drugs .Poor George aka Francois ,getting his walnuts squeezed ..ouch : )

[412069] 08/9/2022 08:14

Phama run by women for woman’s cancers the market will love it.

[jasonpugh] 08/9/2022 08:06

Boom time. Average is 10.9. Looking for at least 3 bagger after deal. Min. 🥰

[wapper] 08/9/2022 07:59

Excellent appointment.Exciting times ahead.

[nico115] 08/9/2022 07:58

Says George who was ousted !!LolThis is great news Gruntling

[francoismyname] 08/9/2022 07:57

More expense in the short term before Suzy goes.

More drain on cash flow.

No income

50% more shares in issue after options.

Suzy to leave within 6 months.

No lab.

No deal.

Yep lots to look forward to.

And by the way you could have sold 3 months ago at 24p

[sweepie2] 08/9/2022 07:52

You just don't get these people with amazing reputations working for you and risking those amazing reputations on something that doesn't work, exciting times coming (keeping the fingers crossed)

[801710245] 08/9/2022 07:51

RE 6020:

That really is an excellent example of a post from a desperate 'de-ramper'.
ten out of ten for fabrication - and/or adding 2 & 2 together and getting about a dozen.

[nico115] 08/9/2022 07:47

Idiot George

[ali g2] 08/9/2022 07:19

These appointments are sounding more and more interesting!

"Having started her career at GlaxoSmithKline, Dr Tralau-Stewart moved into academia where she held senior leadership roles building drug discovery portfolios through to phase 3 clinical studies at Imperial College London, the University of California San Francisco, and the Stanford University-Takeda Alliance for Innovative Medicines.

C4X said Dr Tralau-Stewart was previously involved in advising on, evaluating and due diligence for more than 500 projects, and had supported and facilitated the translation of over 40 therapeutic technologies towards the clinic from academiam.

It described her as an “expert” in transforming therapeutics projects from target identification and validation through lead optimisation to clinical proof-of-concept in many therapeutic areas, including inflammation and neurosciences."

[wulber] 07/9/2022 21:16

Hi JasonWhat is the brewing news on 401 and Black Cat please?